Citations

Clear

448 citation(s) found for "Ja, Fields".

P05.83 Tumor Treating Fields and radiosurgery for supra- and/or infratentorial brain metastases (1–10) from NSCLC in the phase 3 METIS study
Bähr, Oliver , Gondi, Vinai , Ahluwalia, Manmeet S. , Brown, Paul D. , Ahluwalia, Manmeet S , Mehta, Minesh P.

Mayo Clinic

Neuro-Oncology | September 19, 2018 | Volume: 20 | Issue: suppl_3 | Pages: iii322-iii323

10.1093/neuonc/noy139.409 Get It

Breast Cancer Screening: Women's Attitudes and Beliefs in Light of Updated United States Preventive Services Task Force and American Cancer Society Guidelines
Mehta, Jaya , MacLaughlin, Kathy L. , Millstine, Denise , Wallace, Mark R. , Shah, Amit , Fields, Heather , Ruddy, Barbara E., Bryan, Michael , Patel, Bhavika , Temkit, M’hamed , Buras, Matthew , Golafshar, Michael A. , Kling, Juliana M. , Mehta, Jaya M, Millstine, Denise M, Shah, Amit A, Fields, Heather E, Bryan, Michael J, Patel, Bhavika K , Buras, Matthew R , Golafshar, Michael , Kling, Juliana M , Shah, Amit A , Faubion, Stephanie S.

Mayo Clinic

Journal of Women's Health | September 11, 2018 | Volume: 28 | Issue: 3 | Pages: 302-313

10.1089/jwh.2017.6885 | PMID 30204537 Get It

Phase 1b multi-indication study of the antibody drug conjugate anetumab ravtansine in patients with mesothelin-expressing advanced or recurrent malignancies.
Adjei, Alex A. , Philip, Philip Agop, Mercadé, T. Macarulla, Walter, Annette O., Cupit, Lisa, Fields, Scott Z., Holynskyj, Ariadna, Bekaii‐Saab, Tanios , Berlin, Jordan D. , Liu, Rong

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS2607-TPS2607

10.1200/jco.2018.36.15_suppl.tps2607 Get It

Dianhydrogalactitol in bevacizumab-refractory GBM: Further analysis of a phase 1-2 trial.
Shih, Kent C. , Patel, Manish R. , Butowski, Nicholas , Kizilbash, Sani H. , Bacha, Jeffrey , Brown, Dennis , Schwartz, Richard S. , Kanekal, Sarath, Constant, John C.I., Burris, Howard A. , Kizilbash, Sani H , Falchook, Gerald Steven , Jones, Suzanne Fields

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 2061-2061

10.1200/jco.2018.36.15_suppl.2061 Get It

Regenerative Medicine in the State of Florida: Letter Outlining the Florida Organization for Regenerative Medicine
Bu, Guojun , Centanni, John M., Davis, Mary Dabney , Hare, Joshua M. , Fields, Gregg , Jove, Richard, Kenyon, Norma S. , Khan, Aisha , March, Keith L. , Mahmood, Ayesha, Pepine, Carl J. , Zylberberg, Claudia, Zylberberg, Ezequiel, Bruce, Charles J. , Davis, Mary D, Zylberberg, Ezequiel , Bu, Guojun , Davis, Mary D., Dobson, Jon , Matosevic, Sandro , Ricordi, Camillo , Shapiro, Shane A.

Mayo Clinic

Stem Cells Translational Medicine | July 19, 2018 | Volume: 7 | Issue: 7 | Pages: 511-512

10.1002/sctm.18-0066 | PMID 30403444 Get It

A Survey of Patient and Partner Outcome and Treatment Preferences in Mild Cognitive Impairment
Chandler, Melanie , Fields, Julie A. , Aakre, Jeremiah A. , Aakre, Jeremiah, Locke, Dona E.C. , Smith, Glenn E.

Mayo Clinic

Journal of Alzheimer's Disease | May 22, 2018 | Volume: 63 | Issue: 4 | Pages: 1459-1468

10.3233/jad-171161 | PMID 29843239 Get It

Clinicopathological and 123I‐FP‐CIT SPECT correlations in patients with dementia
Jung, Youngsin, Jordan, Lennon, Lowe, Val J. , Kantarci, Kejal , Parisi, Joseph E. , Murray, Melissa E. , Reichard, Ross R., Ferman, Tanis J. , Graff‐Radford, Jonathan , Savica, Rodolfo , Fields, Julie A. , Allen, Laura A., Drubach, Daniel A., Louis, Erik K. St. , Silber, Michael H. , Jack, Clifford R. , Petersen, Ronald C. , Jordan, Lennon G, St Louis, Erik K, Jack, Clifford R , St Louis, E K , Kantarci, Kejal , Murray, Melissa E , Ferman, Tanis J , Dickson, Dennis W. , Jones, David T. , Machulda, Mary M. , Knopman, David S. , Boeve, Bradley F.

Mayo Clinic

Annals of Clinical and Translational Neurology | January 24, 2018 | Volume: 5 | Issue: 3 | Pages: 376-381

10.1002/acn3.521 | PMID 29560382 Get It

AbstractThe relationship between clinicopathologic diagnosis and 123I‐FP‐CIT SPECT in 18 patients with dementia (12 with Lewy body disease) from one center in the United States was assessed. The sensitivity and specificity of abnormal 123I‐FP‐CIT SPECT with reduced striatal uptake on visual inspection for predicting Lewy body disease were 91.7% and 83.3%, respectively. The mean calculated putamen to occipital ratio (mPOR) based on regions of interest was significantly reduced in Lewy body disease compared to non‐Lewy body disease cases (P = 0.002). In this study, abnormal 123I‐FP‐CIT SPECT was strongly associated with underlying Lewy body disease pathology, supporting the utility of 123I‐FP‐CIT SPECT in the clinical diagnosis of dementia with Lewy bodies.
MR Imaging and Cochlear Implants with Retained Internal Magnets: Reducing Artifacts near Highly Inhomogeneous Magnetic Fields
Edmonson, Heidi A. , Carlson, Matthew L. , Patton, Alice , Watson, Robert E. , Patton, Alice C

Mayo Clinic

RadioGraphics | January 10, 2018 | Volume: 38 | Issue: 1 | Pages: 94-106

10.1148/rg.2018170135 | PMID 29320320 Get It

Effects of force fields on the conformational and dynamic properties of amyloid β(1‐40) dimer explored by replica exchange molecular dynamics simulations
Watts, Charles R. , Gregory, Andrew , Frisbie, Cole P., Lovas, Sándor , Frisbie, Cole, Gregory, Andrew

Mayo Clinic

Proteins: Structure, Function, and Bioinformatics | December 13, 2017 | Volume: 86 | Issue: 3 | Pages: 279-300

10.1002/prot.25439 | PMID 29235155 Get It

Abstract The conformational space and structural ensembles of amyloid beta (Aβ) peptides and their oligomers in solution are inherently disordered and proven to be challenging to study. Optimum force field selection for molecular dynamics (MD) simulations and the biophysical relevance of results are still unknown. We compared the conformational space of the Aβ(1‐40) dimers by 300 ns replica exchange MD simulations at physiological temperature (310 K) using: the AMBER‐ff99sb‐ILDN, AMBER‐ff99sb*‐ILDN, AMBER‐ff99sb‐NMR, and CHARMM22* force fields. Statistical comparisons of simulation results to experimental data and previously published simulations utilizing the CHARMM22* and CHARMM36 force fields were performed. All force fields yield sampled ensembles of conformations with collision cross sectional areas for the dimer that are statistically significantly larger than experimental results. All force fields, with the exception of AMBER‐ff99sb‐ILDN (8.8 ± 6.4%) and CHARMM36 (2.7 ± 4.2%), tend to overestimate the α‐helical content compared to experimental CD (5.3 ± 5.2%). Using the AMBER‐ff99sb‐NMR force field resulted in the greatest degree of variance (41.3 ± 12.9%). Except for the AMBER‐ff99sb‐NMR force field, the others tended to under estimate the expected amount of β‐sheet and over estimate the amount of turn/bend/random coil conformations. All force fields, with the exception AMBER‐ff99sb‐NMR, reproduce a theoretically expected β‐sheet‐turn‐β‐sheet conformational motif, however, only the CHARMM22* and CHARMM36 force fields yield results compatible with collapse of the central and C‐terminal hydrophobic cores from residues 17‐21 and 30‐36. Although analyses of essential subspace sampling showed only minor variations between force fields, secondary structures of lowest energy conformers are different.